Novel merwinite/akermanite ceramics: in vitro bioactivity by Mihailova, I K et al.
1 
 
Novel merwinite/akermanite ceramics: in vitro bioactivity  
 
I. K. Mihailova1,*, L. Radev1, V. A. Aleksandrova1, I. V. Colova1, I. M. M. Salvado2, M. H. V. 
Fernandes2 
1 University of Chemical Technology and Metallurgy, 8 St. Kl. Ohridski Blvd., Sofia 1756, 
Bulgaria 
2 University of Aveiro and CICECO, Aveiro, Portugal 
* E-mail : irena@uctm.edu 
Abstract 
The ceramics in the system CaO – MgO – SiO2 has recently received a great deal of attention 
because they exhibit good in vitro bioactivity and have potential use as bone implants. Biphasic 
calcium-magnesium-silicate ceramics was prepared by a sol-gel method. The dried gel with 
chemical composition 3CaO.MgO.2SiO2 was thermally treated at 1300°C for 2 h. The structural 
behavior of the synthesized ceramics was examined by means of X-ray diffraction (XRD), Fourier 
Transform Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM). Merwinite, 
as the main crystalline phase, and akermanite, as the minor phase, were identified. The in vitro 
bioactivity of the synthesized ceramic samples was recorded in Simulated Body Fluid (SBF) for 
different times of soaking. The apatite formation on the surface of the immersed samples was 
detected by FTIR, SEM and Energy Dispersive Spectroscopy (EDS) techniques. The ion 
concentrations in the SBF solutions after the in vitro test were evaluated by Inductively Coupled 
Plasma Optical Emission Spectrometry (ICP-OES).  
On the basis of the results obtained, the ability of the biphasic ceramics to deposit apatite layer 
was found. The peculiarities of the formation of apatite layer depending on the phase composition 
were analyzed and discussed. 
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Introduction 
It is quite natural important societal issues and topics related to health and quality of life to attract 
serious scientific interest. Thus, intensive research has been conducted in recent decades to 
produce new biomaterials for various applications. 
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Biomaterials can be classified as bioinert, bioactive and bioresorbable, based on their chemical 
surface reactivity. Bioactive glasses and ceramics are considered as potential materials for bone 
substitutes, because they can form a direct bond with the living bone. Important requirement for 
bioactive material is that in the presence of biological fluids, an apatite layer is produced on their 
surfaces, which provides the bonding interface with living hard tissues [1]. 
Mg-containing silicate ceramics, glass-ceramics and glasses have proven to be bioactive and 
exhibit numerous advantages for biomedical applications [2, 3]. Their mechanical properties, 
bioactivity and biocompatibility make them promising candidates for bone tissue regeneration 
which explains the growing interest in these materials [3, 4]. The effects of MgO contents on the 
structure, crystallization, degradability and bioactivity of glasses [5], glass-ceramics [6] and 
ceramics [7] in the MgO – CaO – SiO2 – P2O5 system were investigated. Some authors reported 
that the crystallization of the glasses decreased their apatite-formation ability [8]. Various studies 
have investigated ceramics and glass-ceramics in the CaO – MgO – SiO2 system for biomedical 
applications, including merwinite [4, 9–13], akermanite [14–16], diopside [1, 17, 18] and 
monticellite [19, 20] ceramics and glass-ceramics. Diba et al. [3] summarize and discusse the most 
relevant studies carried out in the field of Mg-containing bioactive silicate ceramics and glass-
ceramics.  
Research carried out so far on materials containing merwinite as the main phase reveals their 
promising properties for use as biomaterials [4, 9–13, 21]. The properties of three single-phase 
(merwinite, akermanite, and monticellite) ceramics with different MgO contents were compared 
and the relationship between the chemical composition and the mechanical and biological 
properties was investigated [20]. The results obtained by Chen et al. [21] showed that the 
mechanical properties of bioceramics in the MgO – CaO – SiO2 system were improved from 
merwinite to akermanite and monticellite ceramics with the increase of MgO contents, whereas 
the apatite-formation ability in SBF and cell proliferation decreased. Their results indicated that 
the MgO content was one of the important factors, which distinctly affected the mechanical 
properties and biological performances of bioceramics. 
Despite the positive results of merwinite ceramics bioactivity, the publications related to this phase 
are much less than the ones dedicated to other calcium magnesium silicates as diopside, akermanite 
and more [3]. Furthermore, in a series of publications dedicated to nanocrystalline merwinite, the 
phase is synthesized using the sol-gel molar ratio of TEOS:Mg(NO3)2.6H2O:Ca(NO3)2.4H2O = 
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1:1.44:0.85 [1, 8–13]. This composition of the gel is significantly different from the stoichiometry 
of merwinite and the obtained and tested materials are obviously quite a specific case of merwinite 
bioceramics. In the present study, the composition of the initial gel was selected corresponding to 
the stoichiometry of merwinite 3CaO.MgO.2SiO2 to synthesize ceramics, wherein merwinite is 
prevalent and to examine its structure and bioactive properties.  
Experimental	
Sample preparation 
Ceramics was prepared by sol-gel method using tetraethyl orthosilicate ((C2H5O)4Si, TEOS), 
magnesium nitrate hexahydrate (Mg(NO3)2.6H2O) and calcium nitrate tetrahydrate 
(Ca(NO3)2.4H2O) as raw materials. Nitric acid (HNO3, 2 N) was used to catalyze the hydrolysis of 
TEOS. The TEOS was mixed with absolute ethanol, water and 2N HNO3 (molar ratio: 
TEOS/H2O/HNO3=1:8:0.16) and hydrolyzed for 1 h. under stirring. Then, the solutions of 
Ca(NO3)2.4H2O and Mg2(NO3).6H2O were added into the mixture (molar ratio: 
TEOS/Mg(NO3)2.6H2O/Ca(NO3)2.4H2O = 2:1:3), and reactants were stirred for 6 h at room 
temperature. After mixing, the solution was dried at 100 °C for 2 days to obtain the dry gel. The 
dried gel was calcined at 700 °C for 2 h. Finally, the powders were thermally treated at 1300 °C 
for 2 h. 
Characterization techniques  
X-ray powder diffraction (XRD) analysis was applied for phase identification. An X-ray 
diffractometer Philips at Cu Kα radiation was used in the range from 8° to 90° 2θ (step size: 0.05°, 
counting time per step: 1 s). The crystalline phases were identified using the powder diffraction 
files JCPDS: 35-0591 and JCPDS: 35-0592 from database JCPDS – International Centre for 
Diffraction Data PCPDFWIN v.2.2. (2001). The quantitative phase analysis and the determination 
of unit cell parameters of crystalline phases was performed with the PowderCell 2.4 software [22]. 
FTIR spectroscopy was applied. Infrared transmittance spectra were recorded by using the pressed-
pellet technique in KBr. KBr pellets were prepared by mixing of ~1 mg of the sample with 300 
mg KBr. The measurements were made with a FTIR spectrometer Brucker Tensor 27 in the 
frequency range from 4000 to 400 cm–1. The transmittance spectra were recordered using MCT 
detector with 64 scans and 1 cm-1 resolution.   
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The morphology of the surface and chemical composition were analyzed using Scanning Electron 
Microscopy SEM Hitachi SU‒70 equipped with energy dispersive spectrometer (EDS). 
SBF in vitro test 
In order to estimate the in vitro bioactivity (potential of apatite formation) of the sample, we used 
the Simulated Body Fluid (SBF) proposed by Kokubo et al. [23], the Tris-buffered SBF (Na+ 
142.0, K+ 5.0, Mg2+ 1.5, Ca2+ 2.5, Cl– 147.8, HCO3– 4.2, HPO42– 1.0 and SO42– 0.5 mol m–3; 7.4 
pH). The concentration of various ions in the SBF was adjusted to be similar to those in human 
blood plasma. 
0.3 g of the homogenized ceramic powders were uniaxially pressed to obtain pellets 2 mm in thickness 
and 10 mm in diameter. The pellets were placed in polyethylene bottles containing 20 ml of SBF 
at 37 ± 0.5 °C. The sample surface area to SBF volume (SA/V) ratio was equal to 0.1 cm–1. 
Pellets were removed after 7 and 14 days of soaking, gently rinsed with deionized water and 
acetone, and dried at room temperature. 
Sample surfaces and cross-sections, before and after SBF treatment, were examined by SEM and 
EDS. The changes in the samples during the in vitro test were also registered by FTIR 
spectroscopy. 
The SBF was removed after several periods of immersion and calcium, magnesium, phosphorus, 
and silicon ion concentration in the removed SBF was determined by inductively coupled plasma 
optical emission spectrometry (Prodigy High Dispersion ICP-OES Spectrometer from Teledyne 
Leeman Labs ‒ USA). 
Results and discussion 
• Phase composition and microstructure of ceramic 
XRD data corresponding to the synthesized sample are shown in Fig. 1. Merwinite Ca3MgSi2O8 
(JCPDS: 35-0591), as the main crystalline phase, and akermanite Ca2MgSi2O7 (JCPDS: 35-0592), 
as the minor phase, were identified in ceramic sample sintered at 1300 °C for 2 h. The phase 
composition and lattice parameters for crystalline phases are presented in Table 1. The quantitative 
phase analysis and calculation of the lattice parameters were performed with the PowderCell 2.4 
software. The values of lattice parameters observed for merwinite and akermanite in the ceramic 
were very close to those of the standard JCPDS and thus no difference in their crystal structures 
was detected.  
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As it can be seen, on Fig. 2, the presented FTIR spectrum corresponds to the spectrum of merwinite 
[24, 25]. The intensive bands posited in the range 850-1050 cm-1 correspond to internal 
antisymmetric and symmetric stretching vibrations of SiO4 tetrahedra in merwinite [25].  In the 
same range the most intensive band, posited at 936 cm-1 is related to the non-bridging oxygen 
(NBO) bonds of Si-O-Ca [26]. The other intensive bands in the region 450 to 550 cm-1 could be 
assigned to Si-O-Si bending vibration [25]. In the FTIR spectrum of the thermally treated sample 
(Fig. 2), the peaks near 1022, 936, 885, 530 and 515 cm-1 confirm merwinite as a dominant phase, 
while the peaks near 975, 905, 681, 635 and 472 cm-1 as well as low frequency shoulder around 
850 cm-1 could be related to akermanite [24–28]. Both phases reveal a peaks near 936 and 587 cm-
1. The presented FTIR results are in good agreement with XRD analysis.  
SEM images of the thermally treated ceramic sample before in vitro test are given in Fig. 3. From 
the depicted SEM images of the sample before immersion in SBF it was observed that the surface 
was well crystallized. The euhedral crystals do not exeed 3 µm (Fig. 3 b). 
• In vitro bioactivity of merwinite-akermanite ceramic 
FTIR spectra of the ceramic samples after soaking in SBF solution for 7 and 14 days in static 
conditions are presented at Fig. 4. Four vibrational modes are visible for the PO43- ions in apatite: 
ν1PO43- at 960-966 cm-1, ν2PO43- at 460 cm-1, ν3PO43-  at 1190-980 cm-1, and ν4PO43- at 660-520 
cm-1 [29, 30]. The most intensive peak in the infrared spectra should be the peak arising from 
antisymmetric stretching ν3 of phosphate group. After SBF soaking a gradual change in the 
intensity ratio of the peaks in the spectral range 850-1050 cm-1 occurred which could be an 
indication for increased amount of apatite on the surface.   
In our FTIR results, presented in Fig. 4 some new peaks can be observed. These new peaks were 
posited at 452 (453) cm-1, and 472 (471) cm-1. They could be ascribed to ν2PO43- [31, 32]. The 
additional peaks at 619 (620) cm-1 and 667 cm-1 (for the two samples) were assigned to ν4PO43- 
[33, 34]. On the other hand, the peak centered at 667 cm-1 could be related also to OH- [35]. The 
peak at 903 (906) cm-1 was characteristic of ν1PO43- [36]. In FTIR spectra for the sample after 
soaking for 7 days (Fig. 4, a) one additional peak at 996 was visible, which could be assigned to 
ν1PO43- [37]. 
Furthermore, in the presented FTIR spectra we were able to observe the presence of a series of 
peaks, centered at 718 cm-1, 744 cm-1, and 856 (855) cm-1, which were assigned to ν4CO32- and 
ν2CO32- vibrational modes[38, 39]. 
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From the presented infrared results we could assume that the presence of ν1-ν4 PO43- could be 
related to the crystalline calcium phosphates formed on the surface of the immersed samples. 
Moreover, CaCO3 was also formed on the soaked samples.  
In addition, on the basis of the depicted results four types of regions of ν3CO32-  could be detected: 
1410-1430 cm-1, 1430-1460 cm-1, 1460-1500 cm-1, and 1500-1560 cm-1. In the case of our samples, 
the peaks’ position can be related as follows:  
• For B-type carbonate-containing apatites in which CO32- replaced PO43- at 1416 cm-1 [40], 
1420 cm-1 [41], 1438 (1433) cm-1 [42], 1455 cm-1 [43], 1471 (1476) cm-1 [41], 1486 cm-1 
[44], and 1490 cm-1 [44]. We must note that the peaks at 1420 and 1490 cm-1 could be also 
related to vaterite [39]. The peak centered at 1476 cm-1 was assigned to aragonite, and the 
one at 1438 cm-1 to calcite [39]. 
• For A-type carbonate-containing apatites in which CO32- replaced OH- at 1504 cm-1 [31], 
1517 (1519) cm-1 [45], 1533 (1536) cm-1 [46], and 1552 (1556) cm-1 was found. 
On the basis of the results related to the presence of CO32- bands we can conclude that B-type 
and A-type carbonate-containing apatites were formed on the immersed ceramics. B-type was 
a predominant type for carbonate-containing apatites on the ceramics after in vitro test in SBF 
for 7 and 14 days in static conditions.  
SEM micrographs of the ceramic sample, after immersion in SBF for 7 and 14 days in static 
conditions are presented in Fig. 5. After 7 days of immersion in SBF the surface was fully covered 
by the multiple sphere-like particles (typical size 0.5 - 1 µm) due to the interaction of the ceramic 
surface with the SBF solution (Fig. 5 a, b). The surface of the sample after a longer test period (14 
days) was completely covered by spherical aggregates. On the micrograph (Fig. 5 d) the crystals 
that make up the spherical shapes are easier to distinguish. This type of morphology is typical of 
carbonate-containing apatites formations. 
The detected changes on the sample surface and the identification of the morphology typical of the 
apatite crystalline aggregates made it necessary to conduct an EDS analysis and the obtained data 
is shown in Fig. 6. In this context, EDS analysis proved the presence of large amount of Ca (15.05 
at. %) and P (7.43 at. %). The quantity of Si was 2.92 at. %. Moreover, EDS revealed the presence 
of small amount of Mg (0.91 at. %). On the basis of the results obtained (Ca+Mg)/(Si+P)=1.54. 
This ratio was less than the stoichiometric value of 1.67 for pure apatite, i. e. calcium deficient 
apatite was formed on the surface of the immersed ceramics.  
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On the other hand, after soaking for 14 days (Fig. 6, b), EDS proved the presence of Ca (21.58 at. 
%), P (11.22 at. %), Si (2.09 at. %), and Mg (0.60 at. %), i. e. (Ca+Mg)/(Si+P)=1.67. As it can be 
seen, apatite layer was formed on the surface of the immersed glass-ceramics after 14 days of 
soaking.  
On the basis of the results obtained we can suppose that two types of substitutions can be produced: 
(i) Mg2+→Ca2+ and/or (ii) CO32-→PO43- and SiO44- → PO43- [34].  
The release profiles of Si, Ca, Mg and P ions in SBF at 37 °C for ceramic samples are shown on 
Fig. 7. The ceramic material released Ca and Si ions, and removed P ions from SBF. The 
concentration of Ca in SBF increased from 116 (for SBF solution) to 952 mg/l for ceramics, when 
soaked at 37 ± 0.5 °C for 14 days. The continuous Ca2+ ion dissolution of the ceramics contributed 
to generate an increase in the Ca2+ ion concentration in the SBF despite the formation of apatite 
phase.  During the first and second week, the concentration of Ca in SBF increased rapidly and 
evenly. After 7 days phosphorous ions were fully removed from SBF by the ceramics, because of 
the formation of apatite phase on the surfaces. In addition, SBF was enriched in Si4+ up to a value 
of 57 mg/l for 7 days. After 14 days, a relatively lower concentration of Si was detected. 
After 7 days of soaking, the concentration of Mg in SBF increased slightly from 42 to 53 mg/l but 
after 14 days the concentration decreased and Mg2+ ions were removed from SBF by the ceramics. 
On the one hand, the obtained results suggested low partial dissolution of Mg2+ and Si4+ ions of 
merwinite-akermanite ceramics, on the other hand, the decrease in their concentration during the 
second week of immersion may be due to the their inclusion in the formation of the surface apatite 
layer.  
After 7 days of soaking а depletion of P ion concentration from the SFB solution was found. 
However, this did not delay the apatite-like formation process. The obtained SEM and EDS data 
indicated that the crystallization and growth of the apatite layer continued. Furthermore, with the 
increase of soaking time, the release of Ca2+ led to supersaturation of the Ca ions in the solution 
and aided the formation of apatite like layer. 
The release profile of Ca was similar to the data published by Radev [34] for CaO – SiO2 – P2O5 
glass-ceramics containing β-Ca2SiO4 and Ca15(PO4)2(SiO4)6. The microstructural characteristics 
of the surface after 14 days in SBF were also similar. 
In accordance with Diba et al. [3] the bioactivity mechanism of the Mg-containing silicate 
ceramics is similar to those suggested for Mg-containing bioactive silicate glasses. Studies have 
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shown a relationship between the degradation rate and bioactivity of the ceramics in the CaO – 
MgO – SiO2 system [21]. The key role of degradation in the bioactivity process of these materials 
is correlated to the ion exchange rate of the ceramics/media interface which affects the formation 
of a silica-rich layer on the ceramic surface [1, 3, 47]. The silanol groups formed on the surface 
induce heterogeneous nucleation of apatite, and the released calcium ions increase the ionic 
activity product of apatite, enhancing apatite nucleation. The dissolution behavior of merwinite-
akermanite ceramics was generally in accordance with the previously established apatite-forming 
mechanism. Therefore, the mechanism of apatite formation on the merwinite-akermanite ceramics 
might be similar to that of the CaO – SiO2 – MgO based bioactive ceramics. 
Conclusion 
In conclusion, biphasic merwinite-akermanite bioceramics in the MgO – CaO – SiO2 system was 
prepared first, and then their structural properties and in vitro bioactivity were evaluated. After 7 
days of immersion of the ceramic samples in SBF, sphere-like Ca-P particles were formed on the 
surface and continued to grow during the 14 days of immersion. The results indicated that the 
merwinite-akermanite ceramics had high reactivity in SBF, ability to form an apatite-like layer 
and potentially it might be used as bioactive implant material. The dissolution behavior of ceramics 
was generally in accordance with the previously established apatite-forming mechanism on the 
surface of CaO–SiO2–MgO based bioactive ceramics in SBF.  
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Нова мервинит/акерманитова керамика: in vitro биоактивност 
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Резюме 
Керамиката в системата CaO – MgO – SiO2 напоследък е обект на засилен интерес, защото 
проявява добра in vitro биоактивност и може да се използва за костни импланти. Двуфазна 
калциево-магнезиево-силикатна керамика е получена по зол-гелен метод. Сухият гел с 
химичен състав 3CaO.MgO.2SiO2 е термично третиран при 1300°C за 2 ч. Структурата на 
синтезираната керамика е изследвана с рентгенофазов анализ, инфрачервена спектроскопия 
с Фурие трансформация (ИЧ) и сканираща електронна микроскопия (СЕМ). Установени са 
мервинит, като основна фаза и акерманит – като съпътстваща. Биоактивността in vitro на 
синтезираните керамични образци е определена в симулирана телесна течност (SBF) за 
различно време на потапяне. Образуването на апатит на повърхността на потапяните 
образци е регистрирано с ИЧ, СЕМ и енергийно дисперсивна спектроскопия. Промените в 
концентрацията на йони в SBF след in vitro тестовете е определена с оптична емисионна 
спектроскопия с индуктивно свързана плазма.  
На база на получените резултати добра in vitro биоактивност е установена за двуфазната 
керамика. Анализирани и дискутирани са особеностите на образуване на апатитов слой в 
зависимост от фазовия състав на керамиката. 
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Table and figure captions 
Table 1. Phase composition and lattice parameters for crystalline phases in the ceramics  
 
Fig. 1. X-ray diffraction patterns of merwinite-akermanite ceramics  
Fig. 2. FTIR spectra of thermally treated at 1300 oC for 2 hours ceramics 
Fig. 3 SEM micrographs of the ceramic surface, after thermal treatment at 1300 oC for 2 hours 
Fig 4. FTIR of the prepared ceramics, after immersion in SBF solution for 7 (a) and 14 (b) days 
in static conditions 
Fig. 5. SEM micrographs of the ceramic surface after immersion in SBF for 7 (a, b), and 14 days 
(c, d)  
Fig. 6 EDS data for the ceramic surface, after soaking in SBF for 7 (a) and 14 (b) days in static 
conditions 
Fig. 7. Evolution of elemental concentrations of Ca, Mg, Si, and P in SBF solution measured by 
ICP-OES for different soaking times  
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Fig. 1. X-ray diffraction patterns of merwinite-akermanite ceramics  
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Fig. 2. FTIR spectra of thermally treated at 1200 oC for 2 hours ceramics 
 
  
Fig. 3 SEM micrographs of the ceramic surface, after thermal treatment at 1200 oC for 2 hours 
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Fig 4. FTIR of the prepared ceramics, after immersion in SBF solution for 7 (a) and 14 (b) days 
in static conditions 
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Fig. 5. SEM micrographs of the ceramic surface, after immersion in SBF for 7 (a, b), and 14 days 
(c, d)  
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Fig. 6 EDS data for the ceramic surface, after soaking in SBF for 7 (a) and 14 (b) days in static 
conditions 
 
 
Fig. 7. Evolution of elemental concentrations of Ca, Mg, Si, and P in SBF solution measured by 
ICP-OES for different soaking times  
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Table 1. Phase composition and lattice parameters for crystalline phases in the ceramics  
Crystalline phases Concentration 
(vol. %) 
Lattice parameters 
  a (Å ) b (Å ) c (Å ) β (°) 
Merwinite - a b c β 
Standard JCPDS: 35-0591  - 13.29 5.304 9.352 92.09 
Merwinite in ceramics 85 13.28 5.304 9.336 92.14 
Akermanite - a b   
Standard JCPDS: 35-0592 - 7.833 5.006   
Akermanite in ceramics 15 7.829 5.006   
 
